Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Kalytera Therapeutics Israel, Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT03840512
- Locations
- 🇦🇺
St Vincent's Hospital Sydney - The Kinghorn Cancer Centre, Sydney, Australia
🇮🇱Rambam Health Care - Bone Marrow Transplantation Unit, Haifa, Israel
🇮🇱Hadassah Medical Center - Bone Marrow Transplantation Department, Cancer Immunotherapy and Immunobiology Research Center, Jerusalem, Israel
News
No news found